Literature DB >> 12934049

Relation of C-reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunction.

K L Billups1, D R Kaiser, A S Kelly, R A Wetterling, M Y Tsai, N Hanson, A J Bank.   

Abstract

Erectile dysfunction (ED) may be an early sign or symptom of cardiovascular disease (CVD). We examined the relation of traditional and emerging risk factors for CVD to the severity of penile vascular disease in men with ED and without clinical coronary artery disease (CAD). In total, 137 men with ED were evaluated for penile vascular disease severity by penile Doppler ultrasound. These men were divided into the following groups based on ultrasound results: normal, cavernous venous occlusive disease, mild arterial insufficiency, and severe arterial insufficiency. Traditional (fasting lipid panel, fasting glucose, age, BMI, smoking, Framingham coronary artery disease risk score) and emerging (C-reactive protein, Lp(a), homocysteine) risk factors for CVD were correlated to severity of penile vascular disease in men with ED and without clinical CAD. Using univariate analysis, penile Doppler groups showed significant positive correlation to CRP (r=0.21; < or = 0.05) and age (r=0.30; < or = 0.01). For CRP, this correlation remained significant even when adjusted for age (< or = 0.05). Men displaying evidence of penile arterial disease (mild and severe arterial insufficiency) were characterized by elevated CRP levels (0.17 mg/dl) compared to men with no evidence of arterial abnormalities in the penis (0.04 mg/dl). CRP levels correlate significantly with increasing severity of penile vascular disease as measured by penile Doppler.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12934049     DOI: 10.1038/sj.ijir.3901012

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  18 in total

1.  Occurrence of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome in patients with abdominal obesity. Where is a sufficient level of testosterone?

Authors:  Juraj Fillo; Jan Breza; Michaela Levčíkova; Jan Luha; Anna Vachulova; Štefan Durdík; Peter Labaš
Journal:  Int Urol Nephrol       Date:  2012-08       Impact factor: 2.370

2.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

Review 3.  Emerging role for TNF-α in erectile dysfunction.

Authors:  Fernando S Carneiro; Robert Clinton Webb; Rita C Tostes
Journal:  J Sex Med       Date:  2010-12       Impact factor: 3.802

Review 4.  Erectile dysfunction: interrelationship with the metabolic syndrome.

Authors:  Glenn Matfin; Ali Jawa; Vivian A Fonseca
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

5.  Residual renal function and erectile dysfunction in patients on hemodialysis.

Authors:  Radojica V Stolic; Zoran M Bukumiric; Aleksandar N Jovanovic; Vladan M Peric; Sasa R Sovtic; Branislav P Belic; Nebojsa B Mitic
Journal:  Int Urol Nephrol       Date:  2011-03-05       Impact factor: 2.370

Review 6.  Aetiology and management of male erectile dysfunction and female sexual dysfunction in patients with cardiovascular disease.

Authors:  Stephen L Archer; Ferrante S Gragasin; Linda Webster; Derek Bochinski; Evangelos D Michelakis
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

7.  Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese men.

Authors:  F Giugliano; K Esposito; C Di Palo; M Ciotola; G Giugliano; R Marfella; M D'Armiento; D Giugliano
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

8.  Risk factors for incident erectile dysfunction among community-dwelling men.

Authors:  Susan A Hall; Rebecca Shackelton; Raymond C Rosen; Andre B Araujo
Journal:  J Sex Med       Date:  2009-11-19       Impact factor: 3.802

9.  Assessment of the relationship between asymmetric dimethylarginine and severity of erectile dysfunction and coronary artery disease.

Authors:  Tevfik Aktoz; Meryem Aktoz; Ersan Tatlı; Mustafa Kaplan; Fatma N Turan; Ahmet Barutcu; Irfan H Atakan; Muzaffer Demir; Armagan Altun
Journal:  Int Urol Nephrol       Date:  2010-01-21       Impact factor: 2.370

Review 10.  [Erectile dysfunction: indicator of end-organ damage in cardiovascular patients].

Authors:  Magnus Baumhäkel; Nils Schlimmer; Mario T Kratz; Michael Böhm
Journal:  Med Klin (Munich)       Date:  2009-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.